NCT06118606 Pilot Study of a Multidisciplinary Intervention in ICU Survivors At Risk for Psychological or Physical Morbidity
| NCT ID | NCT06118606 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Region Stockholm |
| Condition | Post-Intensive Care Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-02-01 |
| Primary Completion | 2024-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-02-01 with a primary completion date of 2024-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Pilot study of the feasibility and utility of an early, in-hospital multidisciplinary intervention in ICU survivors at risk for psychological and physical problems post-ICU stay
Eligibility Criteria
Inclusion Criteria: \- Patients admitted ≥12 hours to the ICU with an increased risk for physical or psychological sequelae (assessed with the PROGRESS-ICU/PREPICS instruments) Exclusion Criteria: * Dementia or other major cognitive problems * Structural brain or spinal cord injury * Multiple limitations of medical treatment * Insufficient language skills (Swedish)
Contact & Investigator
Anna Milton
PRINCIPAL INVESTIGATOR
Karolinska Institutet/Karolinska University Hospital
Frequently Asked Questions
Who can join the NCT06118606 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Post-Intensive Care Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06118606 currently recruiting?
Yes, NCT06118606 is actively recruiting participants. Contact the research team at anna.milton@regionstockholm.se for enrollment information.
Where is the NCT06118606 trial being conducted?
This trial is being conducted at Stockholm, Sweden, Stockholm, Sweden.
Who is sponsoring the NCT06118606 clinical trial?
NCT06118606 is sponsored by Region Stockholm. The principal investigator is Anna Milton at Karolinska Institutet/Karolinska University Hospital. The trial plans to enroll 60 participants.